How many shares of ATXI does UBS Group AG own?

UBS Group AG previously held 0 shares of ATXI (Avenue Therapeutics, Inc.) before exiting the position in 2025-Q1.

What is UBS Group AG's ATXI position worth?

UBS Group AG's ATXI position was last reported at $0 in 2025-Q1 before the exit.

In 2025-Q1, UBS Group AG exited their ATXI position entirely (-100.0% change in shares).

Based on available 13F filings, UBS Group AG first reported a position in ATXI in 2019-Q1. They have held the position across 23 quarters.

Position history for UBS Group AG's holdings in Avenue Therapeutics, Inc.

Final Value

Final Shares

Total Value Change

-$23,000

Total Shares Change

-4,785

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$0.31	0
2024-Q4	Increased	7,920	+28.9%	$15,840	0.0%	$1.94	16
2024-Q3	Increased	6,143	+812.8%	$15,296	0.0%	$2.51	20
2024-Q2	New	673	-	$2,356	0.0%	$3.50	18
2024-Q1	Exited	0	-100.0%	$0	0.0%	$11.06	0
2023-Q4	New	1,080	-	$174	0.0%	$12.07	17
2023-Q1	Exited	0	-100.0%	$0	0.0%	$82.50	0
2022-Q4	Increased	1,246	+9.5%	$1,445	0.0%	$87.00	8
2022-Q3	Decreased	1,138	-96.4%	$11,000	0.0%	$543.75	0
2022-Q2	Increased	31,843	+2.8%	$9,000	0.0%	$363.94	12
2022-Q1	Increased	30,984	+13.8%	$15,000	0.0%	$578.02	14
2021-Q4	Increased	27,230	+292.9%	$25,000	0.0%	$991.13	21
2021-Q3	Increased	6,931	+420.7%	$10,000	0.0%	$1,665.00	19
2021-Q2	Decreased	1,331	-76.4%	$3,000	0.0%	$2,823.75	0
2021-Q1	Increased	5,642	+46.5%	$34,000	0.0%	$6,468.75	18
2020-Q4	Increased	3,850	+31.9%	$23,000	0.0%	$6,525.00	16
2020-Q3	Decreased	2,920	-53.9%	$32,000	0.0%	$12,262.50	0
2020-Q2	Increased	6,328	+216.4%	$68,000	0.0%	$12,465.00	23
2020-Q1	Unchanged	2,000	0.0%	$18,000	0.0%	$9,461.25	0
2019-Q4	Decreased	2,000	-57.9%	$19,000	0.0%	$10,552.50	0
2019-Q3	Decreased	4,753	-15.1%	$28,000	0.0%	$6,547.50	0
2019-Q2	Increased	5,597	+17.0%	$36,000	0.0%	$7,087.50	16
2019-Q1	New	4,785	-	$23,000	0.0%	$5,343.75	29